Author:
Assmann G,Hüwel D,Schussman K.-M,Smilde J.G,Kösling M,Withagen A.J.A.M,Wunderlich J,Stoel I,van Dormaal J.J,Neuss J,Oldenbroek C,Cüppers M.C,von Eckardstein A,Schulte H,Wagner B,McLain R,Black D.M
Reference33 articles.
1. Review: declining mortality in coronary heart disease;Levy;Arteriosclerosis,1981
2. Lipid Research Clinics Program, The lipid research clinics coronary primary prevention trial results: I. Reduction in incidence of coronary heart disease, J. Am. Med. Assoc. 151 (1984) 351–364.
3. Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, J. Am. Med. Assoc. 151 (1984) 365–374.
4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B;Brown;N. Engl. J. Med.,1990
5. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol;Stewart;J. Am. Coll. Cardiol.,1994
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HMG coenzyme-A reductase inhibitors;Meyler's Side Effects of Drugs;2016
2. A systematic review and meta-analysis on the therapeutic equivalence of statins;Journal of Clinical Pharmacy and Therapeutics;2009-08-14
3. LIPID – REGULATING DRUGS;Meyler's Side Effects of Endocrine and Metabolic Drugs;2009
4. ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS;MeylerâÂÂs Side Effects of Cardiovascular Drugs;2009
5. HMG coenzyme-A reductase inhibitors;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006